About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5806470
Allelic
Composition
Tg(Ela-KRAS*G12D)9Eps/0
Tgfbr1tm1Bopa/Tgfbr1+
Genetic
Background
involves: 129S1/SvImJ * C57BL/6 * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Ela-KRAS*G12D)9Eps mutation (0 available)
Tgfbr1tm1Bopa mutation (0 available); any Tgfbr1 mutation (36 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• only 40% of mice present with neoplastic or metaplastic pancreatic lesions
• decrease in proliferating cell nuclear antigen (PCNA) staining throughout the entire pancreas

hematopoietic system
• expansion of CD8+ population in mesenteric lymph nodes
• total T-cell infiltration near pancreatic lesions is increased, with strong CD8+ infiltration but almost completely absent CD3/pSMAD2+ and CD3/FOXP3+ cell (suppressive/anergic regulatory T lymphocytes) infiltration, indicating a cytotoxic response against pancreatic lesions

immune system
• expansion of CD8+ population in mesenteric lymph nodes
• total T-cell infiltration near pancreatic lesions is increased, with strong CD8+ infiltration but almost completely absent CD3/pSMAD2+ and CD3/FOXP3+ cell (suppressive/anergic regulatory T lymphocytes) infiltration, indicating a cytotoxic response against pancreatic lesions

neoplasm
• only 40% of mice present with neoplastic or metaplastic pancreatic lesions


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory